Sign In
Buy TRUMY
$14.18
+0.0800 (+0.567%)
At Close: Jun 03, 2026
Terumo Corporation (TRUMF) Q2 2025 Earnings Call Transcript
06:45am, Saturday, 09'th Nov 2024
Terumo Corporation (OTCPK:TRUMF) Q2 2025 Earnings Conference Call November 7, 2024 3:00 AM ET Company Participants Jin Hagimoto – Chief Financial Officer Hikaru Samejima – Chief Executive Officer
Recent Price Trend in Terumo (TRUMY) is Your Friend, Here's Why
09:51am, Wednesday, 30'th Oct 2024
If you are looking for stocks that are well positioned to maintain their recent uptrend, Terumo (TRUMY) could be a great choice. It is one of the several stocks that passed through our "Recent Price S
Terumo (TRUMY) Is a Great Choice for 'Trend' Investors, Here's Why
09:50am, Thursday, 10'th Oct 2024
If you are looking for stocks that are well positioned to maintain their recent uptrend, Terumo (TRUMY) could be a great choice. It is one of the several stocks that passed through our "Recent Price S
Here's Why Momentum in Terumo (TRUMY) Should Keep going
09:50am, Tuesday, 24'th Sep 2024
Terumo (TRUMY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Are You Looking for a Top Momentum Pick? Why Terumo Corp. (TRUMY) is a Great Choice
01:00pm, Friday, 20'th Sep 2024
Does Terumo Corp. (TRUMY) have what it takes to be a top stock pick for momentum investors? Let's find out.
What Makes Terumo (TRUMY) a New Buy Stock
01:01pm, Thursday, 05'th Sep 2024
Terumo (TRUMY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Terumo (TRUMY) Unit Reveals WEB 17 Device Effective in Aneurysms
01:01pm, Thursday, 25'th Jul 2024
Terumo's (TRUMY) subsidiary MicroVention's WEB 17 device, used in treating intracranial aneurysms, demonstrates high safety and effectiveness in the CLEVER study.
Terumo (TRUMY) Unit's SOFAST Study Shows Positive Results
12:51pm, Monday, 15'th Jul 2024
Terumo (TRUMY) subsidiary Microvention's SOFAST study validates the SOFIA Flow Plus Aspiration Catheter's speed, efficacy and safety in stroke thrombectomy.
Terumo Corporation (TRUMY) Q4 2024 Earnings Call Transcript
01:41pm, Thursday, 16'th May 2024
Terumo Corporation (OTCPK:TRUMY) Q4 2024 Results Conference Call May 14, 2024 4:30 AM ET Company Participants Jin Hagimoto - CFO Hikaru Samejima - President, CEO & Director Jin Hagimoto I'm Hagimoto,
Terumo (TRUMY) Moves to Strong Buy: Rationale Behind the Upgrade
01:01pm, Thursday, 28'th Mar 2024
Terumo (TRUMY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Best Momentum Stocks to Buy for March 28th
11:00am, Thursday, 28'th Mar 2024
TRUMY, CIFR and STR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 28, 2023.
New Strong Buy Stocks for March 28th
08:46am, Thursday, 28'th Mar 2024
XRX, REYN, TRUMY, DQ and STR have been added to the Zacks Rank #1 (Strong Buy) List on March 28, 2023.
What Makes Terumo Corp. (TRUMY) a Good Fit for 'Trend Investing'
09:51am, Thursday, 29'th Feb 2024
Terumo Corp. (TRUMY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Terumo Corp. (TRUMY) is on the Move, Here's Why the Trend Could be Sustainable
09:51am, Tuesday, 13'th Feb 2024
Terumo Corp. (TRUMY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Terumo Corporation (TRUMF) Q3 2024 Earnings Call Transcript
07:55pm, Thursday, 08'th Feb 2024
Terumo Corporation (TRUMF) Q3 2024 Earnings Call Transcript
